Sensex

up-green-arrow

Nifty

up-green-arrow

USDINR

down-red-arrow

GBPINR

down-red-arrow

EURINR

down-red-arrow

Company News

Jubilant Pharmova Ltd
Jubilant Pharmova's step-down subsidiary completes US FDA audit with no observations
Sep 22,2025
Jubilant Cadista is a subsidiary of Jubilant Pharma, which is the wholly owned subsidiary Jubilant Pharmova. The said inspection was completed on 19 September 2025. The inspection closed with no observations.

“The above inspection concluded with zero observations, reaffirming Jubilant commitment to maintaining the highest standards of quality, safety, and compliance,” the company said in a statement.

Jubilant Pharmova is a globally present company engaged in radiopharmaceuticals, allergy immunotherapy, CDMO sterile injectables, contract research, development and manufacturing (CRDMO), generics, and proprietary novel drugs businesses.

The company's consolidated net profit declined 78.66% to Rs 102.90 crore despite a 9.21% rise in revenue to Rs 1,878.90 crore in Q1 FY26 over Q1 FY25.

The scrip was up 0.41% to currently trade at Rs 1107.95 on the BSE.

Attention Investor :

"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

A Muthoot M George Enterprise